Cancer BioMarker Array

Cancer BioMarker Antibody Array features 247 unique antibodies against well-studied cancer markers that cover 28 different types of cancer including breast, lung, and colorectal cancer. It is suitable for cancer marker screening for whole cell lysates, tissue lysates, serum, culture media, and other samples. Each package contains two identical array slides for analyzing two samples, such as a control sample and a treatment sample.

Cancer BioMarker Antibody Array is a high-throughput ELISA based antibody array designed for qualitative/semi-quantitative protein expression profiling, comparing normal samples to treated or diseased samples, and identifying candidate biomarkers. This array is specifically designed to detect changes in important markers associated with various cancer types.

Key Features:
· Qualitative/semi-quantitative protein expression profiling with 247 antibodies
· Antibodies covalently immobilized on 3D polymer coated glass slide
· Fluorescent detection

Specifications:
· Product Size: 2 array slides per package for two samples (untreated vs. treated)
· Featured Antibodies: 247 cancer biomarker related antibodies; 6 replicates per antibody
· Reactivity: Human
· Suitable Sample Type: Cell lysate | Tissue lysate | Serum | Culture Media
· Detection Method: Fluorescence | Compatible Scanners
· Internal Controls: Positive controls: beta-actin | GAPDH | Negative controls
· Slide Dimensions: 76 x 25 x 1 mm

Target Proteins:
ACT, ACTH, Adipolean Variant, Adiponectin, AFP, Androgen Receptor, Ang-1, Ang-2, APLP2, ApoE3, ApoF, ApoL1, ApoL2, Beta-2-Microglobulin, beta-NGF, BDNF, CA15-3, CA19-9, CA125, Cadherin-pan, CEA, Collagen I, Collagen II, Collagen III, Collagen IV, CRP, Death Receptor 5, Desmin, DNA mismatch repair protein Mlh1, DNA mismatch repair protein Mlh3, DNA mismatch repair protein Msh2, DNA mismatch repair protein Msh3, DNA mismatch repair protein MSH6, EGF, EGF Receptor, Endoglin(CD105), Eotaxin, Eotaxin-2, Eotaxin-3, Epithelial Cell Adhesion Molecule, E-Selectin, Estrogen Receptor, FAS, Ferritin, Fibroblast Growth Factor acidic (FGF-acidic), Fibroblast Growth Factor basic (FGF-basic), Fibronectin, Flt-1 (VEGFR1), Follicle Stimulating Hormone (FSH), Follistatin, Fractalkine, Free PSA, Granulocyte Colony-Stimulating Factor (G-CSF), Granulocyte/Macrophage Colony-Stimulating Factor (GM-CSF), Granzyme B, and more.

Assay Outline:
The ELISA based Cancer BioMarker Antibody Array platform involves four major steps:
· Protein extraction with non-denaturing lysis buffer
· Biotinylation of protein samples
· Incubation of labeled samples with antibody array
· Detection by dye conjugated streptavidin

Please contact us at for specific academic pricing.

Background

· High-Throughput Antibody Arrays
Our antibody arrays provide a high-throughput, ELISA-based solution for protein expression profiling across samples like cells, tissues, serum, and culture media. It offers greater productivity and cost savings compared to traditional Western Blots or ELISA.

· Comprehensive Protein Profiling
Choose from our comprehensive arrays: Phospho Explorer Array, Signaling Explorer Array, and Explorer Antibody Array. Profile up to 1,358 biomarkers on a single slide, with options tailored to specific pathways in immunology, oncology, and cell biology.

· Phosphorylation Profiling
Our phosphorylation profiling antibody arrays include the Phospho Explorer Array with 1318 antibodies and Pathway Phospho Arrays covering more than 25 different pathways. This platform features phospho-specific antibodies and paired site-specific antibodies for total protein. It is ideal for tyrosine, serine, and threonine phosphorylation analysis.

· High-Quality, Reliable Arrays
Our antibody arrays feature antibodies covalently attached to premium glass with a 3D polymer coating for optimal binding and specificity. Each includes positive/negative controls and multiple replicates for accurate, reliable results.